Medical device company Cohera Medical has secured the Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate the clinical trial of its Sylys Surgical Sealant device.

Sylys Surgical Sealant is designed to be used in conjunction with standard closure techniques for the restoration and protection of anastomotic junctions in colorectal and ileorectal anastomosis procedures.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

It is a resorbable synthetic sealant which helps in reducing anastomotic leakage by offering additional support to anastomosis during the first few days of healing, which is the period witnessing the development of leaks.

"We have made tremendous strides in curtailing the risk associated with intestinal anastomosis, but we are always striving for further improvement and greater patient safety."

Allegheny Health Network in Pittsburgh general surgery programme director James McCormick said: “Anastomotic leakage is the most devastating complication associated with intestinal resection, contributing to morbidity and mortality.

“We have made tremendous strides in curtailing the risk associated with intestinal anastomosis, but we are always striving for further improvement and greater patient safety.”

See Also:

The prospective, multicentre, randomised clinical trial will compare patients undergoing colorectal and ileorectal anastomosis after resection with and without the sealant.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

It is intended to evaluate the safety and efficacy of the sealant in minimising the leak rate involved in these procedures.

The Sylys Surgical Sealant is expected to address the unmet clinical need of the ailment facilitating an improved clinical outcome while minimising patient management costs incurred by the healthcare providers.